Breaking News, Collaborations & Alliances

Jubilant Biosys, Yale Form Research Alliance

Aims to accelerate small molecule discovery programs leveraging Jubilant's medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Jubilant Biosys and Yale University have announced a research collaboration for multiple small molecule research programs.   Under the partnership, Jubilant Biosys will provide research services to investigators at Yale University working on novel therapeutic targets. Areas of collaboration include medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology among others.   “Yale is one of the top-ranked academic institutions in the U.S. and we at Jubilant Biosys are deli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters